Abstract:Programmed cell death (PCD) is fundamentally an indispensable process in all cellular activities, including cell development, wound healing, and immune surveillance of tumors (Gailwiii, L. et al. Cell Death Differ. 2018, 25, 486-541). Malfunctioning of PCD has been shown to be closely related to human diseases such as acute pancreatitis, neurodegenerative diseases, and diverse types of cancers. To date, multiple PCD processes have been discovered and the corresponding regulatory pathways have been elucidated. For example, apoptosis and autophagy are two PCD mechanisms that have been well studied by sophisticated models and probe toolkits. However, limited genetic and chemical tools for other types of PCD hamper the elucidation of their molecular mechanisms. Our group has been studying PCD using both function-oriented synthesis and chemical biology strategies, induding the development of diverse chemical probes based on novel PCD modulators. For instance, in the development of downstream programmed necrosis (or necroptosis) inhibitor necrosulfonamide, we used a chemical probe to unveil a functional protein that was not previously implicated in necroptosis, mixed lineage kinase domain-like protein (MLKL). In addition, high throughput screening and medicinal chemistry enabled the discovery of bioymifi, a small molecule agonist which selectively causes oligomerization of the death receptor 5 (DRS), to induce extrinsic apoptosis. Furthermore, we developed a biomimetic synthetic strategy based on diverse Diels-Alder reactions in the total syntheses of ainsliadimers A and B, ainsliatrimers A and B, and gonchnatiolides A-C, which are natural product inhibitors or activators for PCD. Using synthetic ainsliadimer A probe, we elucidated that ainsliadimer A inhibits the NF-kappa B pathway by covalently binding to Cys46 of IKK beta and triggers apoptosis of cancer cells. We have also revealed that IKK beta is allosterically inhibited by ainsliadimer A. In addition to total synthesis, we have developed a bioorthogonal dick hetero-Diels-Alder cycloaddition of vinyl thioether and o-quinolinone quinone methide (TO z ligation) to facilitate small molecule target identification. The combination of total synthesis and TQ-ligation enables subcellular imaging and identification of the cellular target of ainsliatrimer A to be PPAR gamma. In addition, TQ-ligation has been applied in the discovery of heat shock protein 90 (HSP90) as one of the functional target proteins for kongensin A. We also confirmed that kongensin A covalently attaches to Cys420 within HSP90 and demonstrated that kongensin A blocks the interaction between HSP90 and CDC37 and subsequently inhibits necroptosis. Our development of these diverse PCD modulators provides not only effective chemical tools for fundamental biomedical research, but also the foundation for drug discovery targeting important human diseases such as cancers and inflammation caused by malfunction of PCD.

The advancement of polysaccharides in disease modulation: Multifaceted regulation of programmed cell death

Progress in the Classification of Plant Programmed Cell Death and the Regulatory Protein for Membrane Permeabilization

Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease

Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases

Regulated cell death (RCD) in cancer: key pathways and targeted therapies

Advancements in programmed cell death research in antitumor therapy: a comprehensive overview

Modulation of Apoptosis by Plant Polysaccharides for Exerting Anti-Cancer Effects: A Review

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

Targeting the programmed cell death (PCD) signaling mechanism with natural substances for the treatment of diabetic cardiomyopathy (DCM)

Regulated cell death pathways in cardiomyopathy

Research progress on morphology and mechanism of programmed cell death

Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches

The Therapeutic Potential of Plant Polysaccharides in Metabolic Diseases

Programmed cell death in periodontitis: recent advances and future perspectives

Insights into the molecular mechanisms, structure-activity relationships and application prospects of polysaccharides by regulating Nrf2-mediated antioxidant response

Programming inflammatory cell death for therapy

Colorectal cancer inhibitory properties of polysaccharides and their molecular mechanisms: A review

Dissecting Programmed Cell Death with Small Molecules.

Regulated Cell Death in Pulpitis

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death

Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related Diseases